{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:31:49Z","timestamp":1793665909479,"version":"4.5.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:00:00Z","timestamp":1793664000000},"content-version":"vor","delay-in-days":116,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI069918"],"award-info":[{"award-number":["U01AI069918"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01761-w","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:54:41Z","timestamp":1783709681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of HIV status and vaccination on long COVID conditions within an integrated health care system"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6971-7646","authenticated-orcid":false,"given":"Michael A.","family":"Horberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeena","family":"Jefferson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2119-6044","authenticated-orcid":false,"given":"Seohyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1037-6497","authenticated-orcid":false,"given":"Adrienne N.","family":"Deneal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Gebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenna C.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Humes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri N.","family":"Althoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"1761_CR1","unstructured":"Centers for Disease Control and Prevention. Clinical Overview of Long COVID. (Centers for Disease Control and Prevention, 2024)."},{"key":"1761_CR2","doi-asserted-by":"crossref","unstructured":"Adjaye-Gbweonyo, D., Vahratian, A., Perrine, C. & Bertolli, J. Long COVID in Adults: United States, 2022 (National Center for Health Statistics, 2023).","DOI":"10.15620\/cdc:132417"},{"key":"1761_CR3","unstructured":"World Health Organization. Post COVID-19 Condition (Long COVID). WHO Newsroom Fact Sheets (World Health Organization, 2024)."},{"key":"1761_CR4","doi-asserted-by":"publisher","first-page":"e235856","DOI":"10.1001\/jamanetworkopen.2023.5856","volume":"6","author":"U Chaichana","year":"2023","unstructured":"Chaichana, U. et al. Definition of post-COVID-19 condition among published research studies. JAMA Netw. Open 6, e235856 (2023).","journal-title":"JAMA Netw. Open"},{"key":"1761_CR5","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1056\/NEJMsb2408466","volume":"391","author":"EW Ely","year":"2024","unstructured":"Ely, E. W., Brown, L. M. & Fineberg, H. V. Long covid defined. New Engl. J. Med. 391, 1746\u20131753 (2024).","journal-title":"New Engl. J. Med."},{"key":"1761_CR6","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2023.8823","volume":"329","author":"T Thaweethai","year":"2023","unstructured":"Thaweethai, T. et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA 329, 1934\u20131946 (2023).","journal-title":"JAMA"},{"key":"1761_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33573-6","volume":"13","author":"MA Horberg","year":"2022","unstructured":"Horberg, M. A. et al. Post-acute sequelae of SARS-CoV-2 with clinical condition definitions and comparison in a matched cohort. Nat. Commun. 13, 5822 (2022).","journal-title":"Nat. Commun."},{"key":"1761_CR8","unstructured":"Agency for Healthcare Research and Quality. Clinical Classifications Software Refined (CCSR). Healthcare Cost and Utilization Project (HCUP). (ed. Agency for Healthcare Research and Quality) (Agency for Healthcare Research and Quality, 2024)."},{"key":"1761_CR9","doi-asserted-by":"publisher","first-page":"1297195","DOI":"10.3389\/fimmu.2024.1297195","volume":"15","author":"GA Yendewa","year":"2024","unstructured":"Yendewa, G. A., Perez, J. A., Patil, N. & McComsey, G. A. Associations between post-acute sequelae of SARS-CoV-2, COVID-19 vaccination and HIV infection: a United States cohort study. Front. Immunol. 15, 1297195 (2024).","journal-title":"Front. Immunol."},{"key":"1761_CR10","first-page":"102993","volume":"79","author":"DV Pouliopoulou","year":"2025","unstructured":"Pouliopoulou, D. V. et al. \"Prevalence of post-acute sequelae of SARS-CoV-2 infection in people living with HIV: a systematic review with meta-analysis.\" EClin. Med. 79, 102993 (2025).","journal-title":"EClin. Med."},{"key":"1761_CR11","doi-asserted-by":"crossref","unstructured":"Coburn, S. B. et al. Analysis of postvaccination breakthrough COVID-19 infections among adults with HIV in the United States. JAMA Netw. Open 5, e2215934 (2022).","DOI":"10.1001\/jamanetworkopen.2022.15934"},{"key":"1761_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.7812\/TPP\/22.172","volume":"27","author":"AC Davis","year":"2023","unstructured":"Davis, A. C., Voelkel, J. L., Remmers, C. L., Adams, J. L. & McGlynn, E. A. Comparing Kaiser Permanente members to the general population: implications for generalizability of research. Perm. J. 27, 87\u201398 (2023).","journal-title":"Perm. J."},{"key":"1761_CR13","unstructured":"Chesapeake Regional Information System for our Patients. CRISP Health Information Exchange (Chesapeake Regional Information System for our Patients, 2024)."},{"key":"1761_CR14","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.7326\/M24-0737","volume":"177","author":"KM Erlandson","year":"2024","unstructured":"Erlandson, K. M. et al. Differentiation of prior SARS-CoV-2 infection and postacute sequelae by standard clinical laboratory measurements in the RECOVER cohort. Ann. Intern. Med. 177, 1209\u20131221 (2024).","journal-title":"Ann. Intern. Med."},{"key":"1761_CR15","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/cid\/ciad045","volume":"76","author":"M Gottlieb","year":"2023","unstructured":"Gottlieb, M. et al. Severe fatigue and persistent symptoms at 3 months following severe acute respiratory syndrome coronavirus 2 infections during the pre-Delta, Delta, and Omicron time periods: a multicenter prospective cohort study. Clin. Infect. Dis. 76, 1930\u20131941 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"1761_CR16","first-page":"e49204","volume":"15","author":"N Hulscher","year":"2023","unstructured":"Hulscher, N., Procter, B. C., Wynn, C. & McCullough, P. A. Clinical approach to post-acute sequelae after COVID-19 infection and vaccination. Cureus 15, e49204 (2023).","journal-title":"Cureus"},{"key":"1761_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/pathophysiology30020016","volume":"30","author":"MV Arfijanto","year":"2023","unstructured":"Arfijanto, M. V. et al. Duration of SARS-CoV-2 RNA shedding is significantly influenced by disease severity, bilateral pulmonary infiltrates, antibiotic treatment, and diabetic status: consideration for isolation period. Pathophysiology 30, 186\u2013198 (2023).","journal-title":"Pathophysiology"},{"key":"1761_CR18","doi-asserted-by":"publisher","first-page":"F3","DOI":"10.1097\/QAD.0000000000002666","volume":"34","author":"YB Hadi","year":"2020","unstructured":"Hadi, Y. B., Naqvi, S. F. Z., Kupec, J. T. & Sarwari, A. R. Characteristics and outcomes of COVID-19 in patients with HIV: a multicentre research network study. AIDS 34, F3\u2013F8 (2020).","journal-title":"AIDS"},{"key":"1761_CR19","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1097\/QAD.0000000000003315","volume":"36","author":"W Zhu","year":"2022","unstructured":"Zhu, W. et al. Impact of the coronavirus disease 2019 pandemic on prescriptions for antiretroviral drugs for HIV treatment in the United States, 2019-2021. AIDS 36, 1697\u20131705 (2022).","journal-title":"AIDS"},{"key":"1761_CR20","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","volume":"28","author":"Z Al-Aly","year":"2022","unstructured":"Al-Aly, Z., Bowe, B. & Xie, Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 28, 1461\u20131467 (2022).","journal-title":"Nat. Med."},{"key":"1761_CR21","doi-asserted-by":"crossref","unstructured":"Barth, S., Kulie, P., Monroe, A., Horberg, M. & Castel, A. Prevalence and risk factors for post-COVID conditions of COVID-19 among persons with HIV in Washington, DC. AIDS Care 36, 1358\u20131368 (2024).","DOI":"10.1080\/09540121.2024.2357811"},{"key":"1761_CR22","doi-asserted-by":"publisher","first-page":"F7","DOI":"10.1097\/QAD.0000000000003338","volume":"36","author":"MJ Peluso","year":"2022","unstructured":"Peluso, M. J. et al. Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection. AIDS 36, F7\u2013F16 (2022).","journal-title":"AIDS"},{"key":"1761_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1056\/NEJMoa2403211","volume":"391","author":"Y Xie","year":"2024","unstructured":"Xie, Y., Choi, T. & Al-Aly, Z. Postacute sequelae of SARS-CoV-2 infection in the pre-Delta, Delta, and Omicron Eras. New Engl. J. Med. 391, 515\u2013525 (2024).","journal-title":"New Engl. J. Med."},{"key":"1761_CR24","doi-asserted-by":"publisher","first-page":"e072529","DOI":"10.1136\/bmj-2022-072529","volume":"380","author":"B Mizrahi","year":"2023","unstructured":"Mizrahi, B. et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ 380, e072529 (2023).","journal-title":"BMJ"},{"key":"1761_CR25","doi-asserted-by":"publisher","first-page":"e230010","DOI":"10.1001\/jamahealthforum.2023.0010","volume":"4","author":"A DeVries","year":"2023","unstructured":"DeVries, A., Shambhu, S., Sloop, S. & Overhage, J. M. One-year adverse outcomes among US adults with post-COVID-19 condition vs those without COVID-19 in a large commercial insurance database. JAMA Health Forum 4, e230010 (2023).","journal-title":"JAMA Health Forum"},{"key":"1761_CR26","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1038\/s41591-022-02051-3","volume":"28","author":"B Bowe","year":"2022","unstructured":"Bowe, B., Xie, Y. & Al-Aly, Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med. 28, 2398\u20132405 (2022).","journal-title":"Nat. Med."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01761-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01761-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01761-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:21:04Z","timestamp":1793665264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01761-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1761"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01761-w","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K. Gebo receives royalties from UpToDate, has served on a scientific advisory board for Shionogi and Pfizer (non-compensated), and has received personal consulting fees from Spark HealthCare, Premier HealthCare, Harrison Consulting, and MedEd Learning. All other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"574"}}